MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MITANI, F.
Right arrow Articles by KAPPAS, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MITANI, F.
Right arrow Articles by KAPPAS, A.

Molecular Pharmacology, Vol 7, 689-696, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Interaction of Cytochrome P-450 with Antibodies Raised against a Solubilized P-450 Preparation from Hepatic Microsomes

F. MITANI 1, R. J. WINCHESTER 1, A. P. ALVARES 1, A. P. POLAND 1, and A. KAPPAS 1

1 The Rockefeller University, New York, New York 10021

Soluble cytochrome P-450 prepared from microsomes of rat liver or from livers of chick embryos was shown to be capable of eliciting an immunological response in rabbits. The ggr-globulin fraction from sera of immunized rabbits reacted with soluble P-450 of the same species. Precipitating reactions were obtained when antibody and antigen were incubated in the fluid phase, as well as by agar diffusion techniques. Lack of cross-reactivity between species was demonstrated when antibody to rat cytochrome P-450 was allowed to react with soluble P-450 from chick embryo livers and when antibody to chick cytochrome P-450 was allowed to react with soluble P-450 from rat liver. The Precipitate obtained upon reaction of antibody and antigen from the same species showed a typical CO difference spectrum with an absorption maximum at 450 nm and a type II difference spectrum with aniline. However, no type I difference spectrum could be obtained after the addition of sodium hexobarbital to the antibody-antigen complex, suggesting that the binding site of the immune complex may be at or near the type I binding site.

Submitted on March 23, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics